Abstract：
:The role of Lyn, both a positive and a negative regulator of B and myeloid cells, in chronic lymphocytic leukemia (CLL) has not been well characterized. In this issue of Cancer Cell, Nguyen et al. demonstrated that Lyn in macrophages rather than in CLL cells is critical for the malignancy.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Dong S,Byrd JCdoi
10.1016/j.ccell.2016.09.018subject
Has Abstractpub_date
2016-10-10 00:00:00pages
511-512issue
4eissn
1535-6108issn
1878-3686pii
S1535-6108(16)30453-6journal_volume
30pub_type
评论,杂志文章相关文献
CANCER CELL文献大全abstract：:Identifying contexts in which cancer cells become addicted to specific nutrients is critical for developing targeted metabolic therapies. In this issue of Cancer Cell, Momcilovic et al. report that suppressed glycolysis following mTOR inhibition is countered by adaptive glutamine catabolism in lung squamous cell carci...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2018.04.009
更新日期：2018-05-14 00:00:00
abstract：:One of the biggest challenges in treating acute myeloid leukemia (AML) is relapse of aggressive disease after treatment. In this issue of Cancer Cell, Boyd et al. characterize a molecularly distinct population of chemotherapy-induced transient leukemic regenerating cells (LRCs), which can be exploited to prevent AML r...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2018.08.012
更新日期：2018-09-10 00:00:00
abstract：:The hypoxic tumor microenvironment serves as a niche for maintaining the glioma-initiating cells (GICs) that are critical for glioblastoma (GBM) occurrence and recurrence. Here, we report that hypoxia-induced miR-215 is vital for reprograming GICs to fit the hypoxic microenvironment via suppressing the expression of a...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2015.12.005
更新日期：2016-01-11 00:00:00
abstract：:There is currently much interest in the idea of restoring p53 activity in tumor cells by inhibiting Hdm2/Mdm2. However, it has remained unclear whether this would also activate p53 in normal cells. Using a switchable endogenous p53 mouse model, which allows rapid and reversible toggling of p53 status between wild-type...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2006.10.010
更新日期：2006-12-01 00:00:00
abstract：:BCL-2 proteins are critical for cell survival and are overexpressed in many tumors. ABT-737 is a small-molecule BH3 mimetic that exhibits single-agent activity against lymphoma and small-cell lung cancer in preclinical studies. We here report that ABT-737 effectively kills acute myeloid leukemia blast, progenitor, and...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2006.10.006
更新日期：2006-11-01 00:00:00
abstract：:Monosomy 7 and interstitial deletion of 7q (-7/7q-) are well-recognized nonrandom chromosomal abnormalities frequently found among patients with myelodysplastic syndromes (MDSs) and myeloid leukemias. We previously identified candidate myeloid tumor suppressor genes (SAMD9, SAMD9-like = SAMD9L, and Miki) in the 7q21.3...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.08.011
更新日期：2013-09-09 00:00:00
abstract：:During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, an...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(03)00216-2
更新日期：2003-09-01 00:00:00
abstract：:The MAP3-kinase TGF-beta-activated kinase 1 (TAK1) critically modulates innate and adaptive immune responses and connects cytokine stimulation with activation of inflammatory signaling pathways. Here, we report that conditional ablation of TAK1 in liver parenchymal cells (hepatocytes and cholangiocytes) causes hepatoc...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2010.03.021
更新日期：2010-05-18 00:00:00
abstract：:Somatic loss-of-function mutations in the ten-eleven translocation 2 (TET2) gene occur in a significant proportion of patients with myeloid malignancies. Although there are extensive genetic data implicating TET2 mutations in myeloid transformation, the consequences of Tet2 loss in hematopoietic development have not b...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.06.001
更新日期：2011-07-12 00:00:00
abstract：:Pro-inflammatory cytokines produced in the tumor microenvironment lead to eradication of anti-tumor immunity and enhanced tumor cell survival. In the current study, we identified tumor necrosis factor alpha (TNF-α) as a major factor triggering cancer cell immunosuppression against T cell surveillance via stabilization...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.10.010
更新日期：2016-12-12 00:00:00
abstract：:Targeted protein degradation is an emerging technology for drug development. An article published in Nature reported a novel mechanism of targeted protein degradation triggered by small-molecule-induced polymerization of the oncogenic transcription factor BCL6. ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.12.020
更新日期：2021-01-11 00:00:00
abstract：:The BCL6 gene is a key factor necessary for formation of germinal centers and is implicated in pathogenesis of diffuse large B cell lymphoma (DLBCL). In this issue of Cancer Cell, Saito and colleagues explore regulation of BCL6 gene expression by CD40-NF-kappaB signaling pathway and show that the IRF4 transcriptional ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2007.08.012
更新日期：2007-09-01 00:00:00
abstract：:Besides their function in limiting blood loss and promoting wound healing, experimental evidence has highlighted platelets as active players in all steps of tumorigenesis including tumor growth, tumor cell extravasation, and metastasis. Additionally, thrombocytosis in cancer patients is associated with adverse patient...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2018.03.002
更新日期：2018-06-11 00:00:00
abstract：:Inactivation of the von Hippel-Lindau tumor suppressor gene is linked to the development of hereditary (VHL Disease-associated) and sporadic clear cell carcinoma of the kidney. The VHL gene product, pVHL, targets the heterodimeric transcription factor HIF for polyubiquitination, and restoration of pVHL function in VHL...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(02)00043-0
更新日期：2002-04-01 00:00:00
abstract：:Chronic exposure to tobacco smoke, which contains over 60 tumor-initiating carcinogens, is the major risk factor for development of lung cancer, accounting for a large portion of cancer-related deaths worldwide. It is well established that tobacco smoke is a tumor initiator, but we asked whether it also acts as a tumo...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2009.12.008
更新日期：2010-01-19 00:00:00
abstract：:Although common cancer hallmarks are well established, lineage-restricted oncogenes remain less understood. Here, we report an inherent dependency of melanoma cells on the small GTPase RAB7, identified within a lysosomal gene cluster that distinguishes this malignancy from over 35 tumor types. Analyses in human cells,...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2014.04.030
更新日期：2014-07-14 00:00:00
abstract：:Neuropilin-1 (NRP1) guides the development of the nervous and vascular systems. Binding to either semaphorins or VEGF, NRP1 acts with plexins to regulate neuronal guidance, or with VEGFR2 to mediate vascular development. We have generated two monoclonal antibodies that bind to the Sema- and VEGF-binding domains of NRP...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2006.10.018
更新日期：2007-01-01 00:00:00
abstract：:We report that mouse LSL-KrasG12D;Trp53fl/fl (KP)-mediated lung adenocarcinoma (LADC) tumorigenesis can proceed through both PKCι-dependent and PKCι-independent pathways. The predominant pathway involves PKCι-dependent transformation of bronchoalveolar stem cells (BASCs). However, KP mice harboring conditional knock o...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2019.07.002
更新日期：2019-08-12 00:00:00
abstract：:We evaluated ancestry effects on mutation rates, DNA methylation, and mRNA and miRNA expression among 10,678 patients across 33 cancer types from The Cancer Genome Atlas. We demonstrated that cancer subtypes and ancestry-related technical artifacts are important confounders that have been insufficiently accounted for....
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.04.012
更新日期：2020-05-11 00:00:00
abstract：:Adenosine deaminase associated with RNA1 (ADAR1) deregulation contributes to therapeutic resistance in many malignancies. Here we show that ADAR1-induced hyper-editing in normal human hematopoietic progenitors impairs miR-26a maturation, which represses CDKN1A expression indirectly via EZH2, thereby accelerating cell-...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2018.11.017
更新日期：2019-01-14 00:00:00
abstract：:Although signaling from phosphatidylinositol 3-kinase (PI3K) and AKT to mechanistic target of rapamycin (mTOR) is prominently dysregulated in high-grade glial brain tumors, blockade of PI3K or AKT minimally affects downstream mTOR activity in glioma. Allosteric mTOR inhibitors, such as rapamycin, incompletely block mT...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2017.01.014
更新日期：2017-03-13 00:00:00
abstract：:Women with ErbB2-positive breast cancer have a poor prognosis, and frequently, chemotherapy treatment is ineffective. The ErbB2-targeted antibody trastuzumab improves survival when given with chemotherapy to patients with ErbB2-overexpressing metastatic disease, but treatment is not curative, and primary resistance is...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2004.08.001
更新日期：2004-08-01 00:00:00
abstract：:Neuro-glial activation is a recently identified hallmark of growing cancers. Targeting tumor hyperinnervation in preclinical and small clinical trials has yielded promising antitumor effects, highlighting the need of systematic analysis of neural influences in cancer (NIC). Here, we outline the strategies translating ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.05.023
更新日期：2020-07-13 00:00:00
abstract：:p62 is a ubiquitin-binding autophagy receptor and signaling protein that accumulates in premalignant liver diseases and most hepatocellular carcinomas (HCCs). Although p62 was proposed to participate in the formation of benign adenomas in autophagy-deficient livers, its role in HCC initiation was not explored. Here we...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.04.006
更新日期：2016-06-13 00:00:00
abstract：:Therapies for KRas cancers remain a major clinical need. In the current issue of Cancer Cell, Sanclemente and coworkers in Mariano Barbacid's group validate c-Raf as a prime target for these cancers. c-Raf ablation caused regression of advanced KRasG12V/Trp53 tumors, without obvious systemic toxicity and without affec...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2018.01.017
更新日期：2018-02-12 00:00:00
abstract：:Angiogenesis is a hallmark of solid tumors, and disruption of tumor vasculature is an active anticancer therapy in some cases. Several proteins expressed on the surface of tumor endothelium have been identified during the last decade. However, due to the expression in both physiological and tumor angiogenesis, only a ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2007.05.004
更新日期：2007-06-01 00:00:00
abstract：:Immune cells' metabolism influences their differentiation and function. Given that a complex interplay of environmental factors within the tumor microenvironment (TME) can have a profound impact on the metabolic activities of immune, stromal, and tumor cell types, there is emerging interest to advance understanding of...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccell.2020.09.004
更新日期：2021-01-11 00:00:00
abstract：:Defective V(D)J rearrangement of immunoglobulin heavy or light chain (IgH or IgL) or class switch recombination (CSR) can initiate chromosomal translocations. The DNA-damage kinase ATM is required for the suppression of chromosomal translocations but ATM regulation is incompletely understood. Here, we show that mice l...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2011.03.022
更新日期：2011-05-17 00:00:00
abstract：:The TFAP2C/AP-2γ transcription factor regulates luminal breast cancer genes, and loss of TFAP2C induces epithelial-mesenchymal transition. By contrast, the highly homologous family member, TFAP2A, lacks transcriptional activity at luminal gene promoters. A detailed structure-function analysis identified that sumoylati...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2014.04.008
更新日期：2014-06-16 00:00:00
abstract：:Members of the KDM5 histone H3 lysine 4 demethylase family are associated with therapeutic resistance, including endocrine resistance in breast cancer, but the underlying mechanism is poorly defined. Here we show that genetic deletion of KDM5A/B or inhibition of KDM5 activity increases sensitivity to anti-estrogens by...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2018.10.014
更新日期：2018-12-10 00:00:00
